|
1
|
Howlader N, Noone AM, Krapcho M, Garshell
J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,
Mariotto A, Lewis DR, Chen HS, Feuer EJ and Cronin KA: SEER Cancer
Statistics Review. 1975–2011, National Cancer Institute; Bethesda,
MD: http://seer.cancer.gov/csr/1975_2011/September
17–2014
|
|
2
|
Sipos JA and Mazzaferri EL: Thyroid cancer
epidemiology and prognostic variables. Clin Oncol (R Coll Radiol).
22:395–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carcangiu ML, Zampi G, Pupi A, Castagnoli
A and Rosai J: Papillary carcinoma of the thyroid = A
clinicopathologic study of 241 cases treated at the University of
Florence, Italy. Cancer. 55:805–828. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Albores-Saavedra J and Wu J: The many
faces and mimics of papillary thyroid carcinoma. Endocr Pathol.
17:1–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tielens ET, Sherman SI, Hruban RH and
Ladenson PW: Follicular variant of papillary thyroid carcinoma: a
clinicopathologic study. Cancer. 73:424–431. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sebastian SO, Gonzalez JM, Paricio PP,
Perez JS, Flores DP, Madrona AP, Romero PR and Tebar FJ: Papillary
thyroid carcinoma: prognostic index for survival including the
histological variety. Arch Surg. 135:272–277. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zidan J, Karen D, Stein M, Rosenblatt E,
Basher W and Kuten A: Pure versus follicular variant of papillary
thyroid carcinoma: clinical features, prognostic factors, treatment
and survival. Cancer. 97:1181–1185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lang BH, Lo CY, Chan WF, Lam AK and Wan
KY: Classical and follicular variant of papillary thyroid
carcinoma: a comparative study on clinicopathologic features and
long-term outcome. World J Surg. 30:752–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lam AK, Lo CY and Lam KS: Papillary
carcinoma of thyroid: A 30-yr clinicopathological review of the
histological variants. Endocr Pathol. 16:323–330. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang HY, Lin JD, Chou SC, Chao TC and
Hsueh C: Clinical presentations and outcomes of surgical treatment
of follicular variant of the papillary thyroid carcinomas. Jpn J
Clin Oncol. 36:688–693. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin HW and Bhattacharyya N: Clinical
behavior of follicular variant of papillary thyroid carcinoma:
presentation and survival. Laryngoscop. 120:712–716. 2010.
View Article : Google Scholar
|
|
12
|
Passler C, Prager G, Scheuba C, Niederle
BE, Kaserer K, Zettinig G and Niederle B: Follicular variant of
papillary thyroid carcinoma: a long-term follow-up. Arch Surg.
138:1362–1366. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Crile GJ and Hazard JB: Relationship of
the age of the patient to the natural history and prognosis of
carcinoma of the thyroid. Ann Surg. 138:33–38. 1953. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ertek S, Yilmaz NC, Cicero AF, Vurupalmaz
O, Demiroz AS and Erdogan G: Increasing diagnosis of thyroid
papillary carcinoma follicular variant in south-east Anatolian
region: comparison of characteristics of classical papillary and
follicular variant thyroid cancers. Endocr Pathol. 23:157–160.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
LiVolsi VA and Asa SL: The demise of
follicular carcinoma of the thyroid gland. Thyroid. 4:233–236.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuksel O, Kurukahvecioglu O, Ege B, Ekinci
O, Aydin A, Poyraz A, Tezel E and Taneri F: The relation between
pure papillary and follicular variant in papillary thyroid
carcinoma. Endocr Regul. 42:29–33. 2008.PubMed/NCBI
|
|
17
|
Ozdemir D, Ersoy R, Cuhaci N, Arpaci D,
Ersoy EP, Korukluoglu B, Guler G and Cakir B: Classical and
follicular variant papillary thyroid carcinoma: comparison of
clinical, ultrasonographical, cytological and histopathological
features in 444 patients. Endocr Pathol. 22:58–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng S, Serra S, Mercado M, Ezzat S and
Asa SL: A high-throughput proteomic approach provides distinct
signatures for thyroid cancer behavior. Clin Cancer Res.
17:2385–2394. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burningham AR, Krishnan J, Davidson BJ,
Ringel MD and Burman KD: Papillary and follicular variant of
papillary carcinoma of the thyroid: Initial presentation and
response to therapy. Otolaryngol Head Neck Surg. 132:840–844. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hagag P, Hod N, Kummer E, Cohenpour M,
Horne T and Weiss M: Follicular variant of papillary thyroid
carcinoma: clinical-pathological characterization and long-term
follow-up. Cancer J. 12:275–282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stroup DF, Berlin JA, Morton SC, Olkin I,
Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker
SB: Meta-analysis of observational studies in epidemiology: a
proposal for reporting. Meta-analysis of observational studies in
epidemiology (MOOSE) group. JAMA. 283:20082012. View Article : Google Scholar
|
|
22
|
Abrosimov A, Saenko V, Meirmanov S,
Nakashima M, Rogounovitch T, Shkurko O, Lushnikov E, Mitsutake N,
Namba H and Yamashita S: The cytoplasmic expression of MUC1 in
papillary thyroid carcinoma of different histological variants and
its correlation with cyclin D1 overexpression. Endocr Pathol.
18:68–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brzezianska E, Pastuszak-Lewandoska D,
Wojciechowska K, Migdalska-Sek M, Cyniak-Magierska A, Nawrot E and
Lewinski A: Investigation of V600E BRAF mutation in papillary
thyroid carcinoma in the Polish population. Neuro Endocrinol Lett.
28:351–359. 2007.PubMed/NCBI
|
|
24
|
Costa AM, Herrero A, Fresno MF, Heymann J,
Alvarez JA, Cameselle-Teijeiro J and Garcia-Rostan G: BRAF mutation
associated with other genetic events identifies a subset of
aggressive papillary thyroid carcinoma. Clin Endocrinol (Oxf).
68:618–634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Daglar-Aday A, Toptas B, Ozturk T, Seyhan
F, Saygili N, Eronat AP, Akadam-Teker B, Yilmaz-Aydogan H, Aksoy F
and Ozturk O: Investigation of BRAF V600E mutation in papillary
thyroid carcinoma and tumor-surrounding nontumoral tissues. DNA
Cell Biol. 32:13–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Darr EA, Patel AD, Yu G, Komorowski Z,
McCormick S, Tiwari R, Schantz SP and Geliebter J: Reduced Cx43 gap
junction plaque expression differentiates thyroid carcinomas from
benign disease. Arch Otolaryngol Head Neck Surg. 137:1161–1165.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dettmer M, Perren A, Moch H, Komminoth P,
Nikiforov YE and Nikiforova MN: Comprehensive MicroRNA expression
profiling identifies novel markers in follicular variant of
papillary thyroid carcinoma. Thyroid. 23:1383–1389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Di Cristofaro J, Marcy M, Vasko V, Sebag
F, Fakhry N, Wynford-Thomas D and De Micco C: Molecular genetic
study comparing follicular variant versus classic papillary thyroid
carcinomas: association of N-ras mutation in codon 61 with
follicular variant. Hum Pathol. 37:824–830. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eloy C, Santos J, Soares P and
Sobrinho-Simoes M: The preeminence of growth pattern and
invasiveness and the limited influence of BRAF and RAS mutations in
the occurrence of papillary thyroid carcinoma lymph node
metastases. Virchows Arch. 459:265–276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Espadinha C, Santos JR, Sobrinho LG and
Bugalho MJ: Expression of iodine metabolism genes in human thyroid
tissues: evidence for age and BRAFV600E mutation dependency. Clin
Endocrinol (Oxf). 70:629–635. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao WL, Wie LL, Chao YG, Wie L and Song
TL: Prognostic prediction of BRAF (V600E) and its relationship with
sodium iodide symporter in classic variant of papillary thyroid
carcinomas. Clin Lab. 58:919–926. 2012.PubMed/NCBI
|
|
32
|
Hunt JL, Fowler M, Lomago D, Niehouse L,
Sasatomi E, Swalsky P and Finkelstein S: Tumor suppressor gene
allelic loss profiles of the variants of papillary thyroid
carcinoma. Diagn Mol Pathol. 13:41–46. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Igci YZ, Erkilic S, Igci M and Arslan A:
MCM3 Protein expression in follicular and classical variants of
papillary thyroid carcinoma. Pathol Oncol Res. 20:87–91. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Igci YZ, Erkilic S and Arslan A: Septin 7
immunoexpression in papillary thyroid carcinoma: a preliminary
study. Pathol Res Pract. 210:426–431. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ito Y, Hirokawa M, Uruno T, Kihara M,
Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F and
Miyauchi A: Prevalence and biological behaviour of variants of
papillary thyroid carcinoma: experience at a single institute.
Pathology. 40:617–622. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lassalle S, Hofman V, Ilie M, Bonnetaud C,
Puissegur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud
B, Lebrigand K, Rios G, Santini J, Franc B, Mari B, Al Ghuzlan A,
Vielh P, Barbry P and Hofman P: Can the microRNA signature
distinguish between thyroid tumors of uncertain malignant potential
and other well-differentiated tumors of the thyroid gland? Endocr
Relat Cancer. 18:579–594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee S, Han BK, Ko EY, Oh YL, Choe JH and
Shin JH: The ultrasonography features of hyalinizing trabecular
tumor of the thyroid are more consistent with its benign behavior
than cytology or frozen section readings. Thyroid. 21:253–259.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lim JY, Hong SW, Lee YS, Kim BW, Park CS,
Chang HS and Cho JY: Clinicopathologic implications of the BRAF
(V600E) mutation in papillary thyroid cancer: a subgroup analysis
of 3130 cases in a single center. Thyroid. 23:1423–1430. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Z, Liu D, Bojdani E, El-Naggar AK,
Vasko V and Xing M: IQGAP1 plays an important role in the
invasiveness of thyroid cancer. Clin Cancer Res. 16:6009–6018.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Min HS, Lee C and Jung KC: Correlation of
immunohistochemical markers and BRAF mutation status with
histological variants of papillary thyroid carcinoma in the Korean
population. J Korean Med Sci. 28:534–541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nechifor-Boila A, Borda A, Sassolas G,
Hafdi-Nejjari Z, Borson-Chazot F, Lifante J, C, Sturm N, Laverriere
MH, Berger N and Decaussin-Petrucci M: Immunohistochemical markers
in the diagnosis of papillary thyroid carcinomas: The promising
role of combined immunostaining using HBME-1 and CD56. Pathol Res
Pract. 209:585–592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Oler G and Cerutti JM: High prevalence of
BRAF mutation in a Brazilian cohort of patients with sporadic
papillary thyroid carcinomas: correlation with more aggressive
phenotype and decreased expression of iodide-metabolizing genes.
Cancer. 115:972–980. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rivera M, Tuttle RM, Patel S, Shaha A,
Shah JP and Ghossein RA: Encapsulated papillary thyroid carcinoma:
a clinico-pathologic study of 106 cases with emphasis on its
morphologic subtypes (histologic growth pattern). Thyroid.
19:119–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schulten HJ, Salama S, Al-Mansouri Z,
Alotibi R, Al-Ghamdi K, Al-Hamour OA, Sayadi H, Al-Aradati H,
Al-Johari A, Huwait E, Gari M, Al-Qahtani MH and Al-Maghrabi J:
BRAF mutations in thyroid tumors from an ethnically diverse group.
Hered Cancer Clin Pract. 10:102012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sheu SY, Grabellus F, Schwertheim S, Worm
K, Broecker-Preuss M and Schmid KW: Differential miRNA expression
profiles in variants of papillary thyroid carcinoma and
encapsulated follicular thyroid tumours. Br J Cancer. 102:376–382.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Slosar M, Vohra P, Prasad M, Fischer A,
Quinlan R and Khan A: Insulin-like growth factor mRNA binding
protein 3 (IMP3) is differentially expressed in benign and
malignant follicular patterned thyroid tumors. Endocr Pathol.
20:149–157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Trovisco V, Soares P, Preto A, de Castro
IV, Lima J, Castro P, Maximo V, Botelho T, Moreira S, Meireles AM,
Magalhaes J, Abrosimov A, Cameselle-Teijeiro J and Sobrinho-Simoes
M: Type and prevalence of BRAF mutations are closely associated
with papillary thyroid carcinoma histotype and patients' age but
not with tumour aggressiveness. Virchows Arch. 446:589–595. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wreesmann VB, Ghossein RA, Hezel M,
Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH and Singh B:
Follicular variant of papillary thyroid carcinoma: genome-wide
appraisal of a controversial entity. Genes Chromosomes Cancer.
40:355–364. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jain M, Khan A, Patwardhan N, Reale F and
Safran M: Follicular variant of papillary thyroid carcinoma: a
comparative study of histopathologic features and cytology results
in 141 patients. Endocr Pract. 7:79–84. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kim DS, Kim JH, Na DG, Park SH, Kim E,
Chang KH, Sohn CH and Choi YH: Sonographic features of follicular
variant papillary thyroid carcinomas in comparison with
conventional papillary thyroid carcinomas. J Ultrasound Med.
28:1685–1692. 2009.PubMed/NCBI
|
|
51
|
Salajegheh A, Petcu EB, Smith RA and Lam
AK: Follicular variant of papillary thyroid carcinoma: a diagnostic
challenge for clinicians and pathologists. Postgrad Med J.
84:78–82. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lee JH, Lee ES and Kim YS:
Clinicopathologic significance of BRAF V600E mutation in papillary
carcinomas of the thyroid: a meta-analysis. Cancer. 110:38–46.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK,
Lee YJ, Kim KW, Hahn SK, Youn YK, Kim KH, Cho BY and Park do J: The
association of the BRAF (V600E) mutation with prognostic factors
and poor clinical outcome in papillary thyroid cancer: a
meta-analysis. Cancer. 118:1764–1773. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tufano RP, Teixeira GV, Bishop J, Carson
KA and Xing M: BRAF mutation in papillary thyroid cancer and its
value in tailoring initial treatment: a systematic review and
meta-analysis. Medicine (Baltimore). 91:274–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li C, Lee KC, Schneider EB and Zeiger MA:
BRAF V600E mutation and its association with clinicopathological
features of papillary thyroid cancer: a meta-analysis. J Clin
Endocrinol Metab. 97:4559–4570. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu X, Yan K, Lin X, Zhao L, An W, Wang C
and Liu X: The association between BRAF V600E mutation and
pathological features in PTC. Eur Arch Otorhinolaryngol. 271:Jan
4–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yu XM, Schneider DF, Leverson G, Chen H
and Sippel RS: Follicular variant of papillary thyroid carcinoma is
a unique clinical entity: a population-based study of 10,740 cases.
Thyroid. 23:1263–1268. 2013. View Article : Google Scholar : PubMed/NCBI
|
